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Abstract
Background The aim of this study was to examine the rela-
tionship between urine ethanol concentration and alcohol
hangover severity.
Methods N = 36 healthy social drinkers participated in a nat-
uralistic study, comprising a hangover day and a control day.
N = 18 of them have regular hangovers (the hangover group),
while the other N = 18 claim to be hangover immune (hang-
over-immune group). On each test day at 9.30 am, urine sam-
ples were collected. Participants rated their overall hangover
severity on a scale from 0 (absent) to 10 (extreme), as well as
18 individual hangover symptoms.
Results Urine ethanol concentration was significantly higher
on the hangover day when compared to the control day
(p = 0.006). On the hangover day, urine ethanol concentration
was significantly lower in the hangover-immune group when
compared to the hangover group (p = 0.027). In the hangover-
immune group, none of the correlations of urine ethanol con-
centration with individual hangover symptoms was signifi-
cant. In contrast, in the hangover group, significant correla-
tions were found with a variety of hangover symptoms, in-
cluding nausea, concentration problems, sleepiness,
weakness, apathy, sweating, stomach pain, thirst, heart racing,
anxiety, and sleep problems.
Conclusion Urine ethanol levels are significantly associated
with the presence and severity of several hangover symptoms.
Keywords Ethanol . Alcohol . Hangover . Severity
Introduction
Alcohol hangover is often described as the combination of
symptoms experienced the day after an evening of heavy al-
cohol consumption (Verster et al. 2010). Frequently reported
symptoms include being tired, thirsty, drowsiness, sleepiness,
headache, dry mouth, nausea, weakness, concentrations prob-
lems, and reduced alertness (Penning et al. 2012). A factor
analysis to categorize 49 hangover-related symptoms revealed
that the two most important factors were related to drowsiness
and impaired cognitive functioning (Penning et al. 2012).
The relationship between the amount of consumed alcohol
and the presence and severity of hangover symptoms is not
straightforward. Although at a group level, it is correct that
hangovers are usually more severe if more alcohol has been
consumed; this is not always true for individual drinkers
(Penning et al. 2010). Moreover, after consuming the same
amount of alcohol, a drinker may experience a hangover on
one occasion, but not on a comparable other drinking occa-
sion. Thus, the presence and severity of hangover symptoms
vary between drinkers and may also vary between drinking
occasions. Only few studies examined this topic and reported
inconclusive results. For example, Ylikahri et al. (1974) found
no significant correlation between peak blood alcohol concen-
tration and hangover severity in 23 healthy students after
drinking alcohol (1.5 g/kg), whereas Kruisselbrink et al.
(2006) did report a significant relationship between hangover
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severity and the administered dose of alcohol. To complicate
matters, there is also a group of drinkers that claim not to
experience hangovers, i.e., the hangover-immune group, de-
spite consuming large quantities of alcohol. A review of both
controlled experimental studies and surveys (Howland et al.
2008) concluded that this group of hangover-immune drinkers
comprises about 25 % of social drinkers. In real life, however,
peak BAC values can be much higher than those administered
in experimental studies (Verster et al. 2015). Data from a large
survey among Dutch students revealed that the majority of
drinkers who claim to be hangover immune do not reach an
estimated BAC of 0.08 % (Verster et al. 2013) and confirmed
that most social drinkers who claim to be hangover immune
simply do not drink sufficient quantities of alcohol to provoke
a hangover per se. The data showed that with increasing esti-
mated BACs, the percentage of drinkers claiming to be hang-
over immune reduces significantly. Nevertheless, a small per-
centage of heavy drinkers persists in claiming to be hangover
immune, despite having peak BACs above 0.15 %.
The current study examined the relationship between
breath and urine ethanol concentration and hangover severity
in social drinkers, of which half reported a hangover and the




This naturalistic study comprised a hangover day and a control
day (no alcohol consumed the previous day). Data were col-
lected on test days following real-life drinking sessions. No
constraints are imposed upon participants’ behavior in this
observational study, and the investigators were not present
during the drinking session or on the control day. The
University of Groningen Psychology Ethics Committee ap-
proved the study. Written informed consent was obtained be-
fore the start of the study.
Participants
Healthy social drinkers, 18–30 years old, were recruited to
participate in the study. They should report having occasions
on which they consume at least five alcoholic beverages, at
least three times per month. The advertisement made clear that
we were recruiting two types of social drinkers: (1) those who
have hangovers after an evening of alcohol consumption and
(2) those that do not have hangovers after an evening of alco-
hol consumption. To verify whether participants consume suf-
ficient amounts of alcohol to produce an alcohol hangover per
se, their estimated peak breath alcohol concentration (BAC)
on such occasions was computed. Estimated BAC should be
above 0.08 % and was computed using the formula of
Mathews and Miller (1979), taking into account the number
of drinks consumed within a certain time frame, controlling
for gender and bodyweight. Drug use was verified using urine
drug tests on the test days, and participants who scored posi-
tive were excluded from participation. Participants were allo-
cated to one of two groups: (1) N = 18 participants who report
experiencing hangovers after reaching this estimated BAC
and (2) N = 18 participants who reported that they never
experiencing alcohol hangovers, despite regularly consuming
alcohol corresponding to estimated BACs higher than 0.08 %.
Procedures
Participants consumed alcohol (or not) at their own pace,
quantity, and in a setting of their own choice. Test days were
postponed if participants chose not to consume alcohol.
Participants were asked not to consume alcohol at least 24 h
before the control test day, not to use recreational drugs, and
not to consume any caffeinated beverages on test days.
On both the hangover day and a control day, a urine sample
was collected at 9.30 am, and several subjective assessments
were made. Urine was tested (InstantView) for the presence of
amphetamines (including MDMA), barbiturates, cannabi-
noids, benzodiazepines, cocaine, and opiates, and the remain-
ing urine was stored for ethanol determination.
Participants completed a questionnaire regarding last
evening’s drinking behavior (including start and stop
time of alcohol consumption and the number and type
of drinks consumed) to enable calculation of the estimat-
ed peak BAC for each participant. Overall hangover se-
verity and the severity of 18 individual hangover symp-
toms were assessed, including headache, nausea, concen-
tration problems, regret, sleepiness, heart beating,
vomiting, tired, shaking, clumsy, weakness, dizziness,
apathy, sweating, stomach pain, confusion, light sensitiv-
ity, thirst, heart racing, anxiety, depression, reduced ap-
petite, and sleep problems. The presence and severity of
overall hangover severity and each symptom individually
were rated using 10-point scales, ranging from absent (0)
to extreme (10).
Urine collection, handling, and analysis
On each test day, a urine sample was collected at 09.30 am.Any
turbid urine samples were centrifuged at 3000 rpm for 15min at
room temperature. The urine was stored in three 3-mL
cryovials, at a temperature of −20 °C. Urine ethanol concentra-
tion was determined using headspace gas chromatography with
flame ionization detection. The separation was performed on a
Porapak Q packed column. Samples were spiked with 1-
propanol as an internal standard (IS). Together with the head-
space syringe, the samples were heated at 80 °C for 20min. The
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gas phase in the vial was manually injected into the column of
the headspace chromatograph. The temperature of the column
oven was set at 140 °C for 9 min. After the elution of the IS, the
temperature was increased to 200 °C for 5 min to remove any
late eluting sample compounds from the column. For each stan-
dard curve sample, peak ratio of ethanol to the ISwas calculated
and plotted against the ethanol concentration. Results from
urine samples from participants were plotted in the calibration
curve, calculating ethanol concentrations using the correspond-
ing formula.
Statistical analyses
Statistical analyses were performed with SPSS, version 23.
Urine ethanol concentration of the hangover and control day
were compared using the Mann-Whitney U test. Delta scores
(hangover—control day) were computed for each variable.
Delta ethanol concentration was correlated (nonparametric,
Spearman’s rho) with overall hangover severity and severity
scores for the individual hangover symptoms. The analyses
were conducted for all participants together (N = 36) and sep-
arate for the hangover group (N = 18) and the hangover-
immune group (N = 18).
Results
Participants of the hangover-immune group (N = 18) and
hangover group (N = 18) respectively did not differ signifi-
cantly in mean ± SD age (20.8 ± 2.0 versus 21.4 ± 1.6 years
old), height (1.79 ± 0.1 versus 1.76 ± 0.1 m), and weight
(71.1 ± 10.2 versus 67.2 ± 11.5 kg). Regarding alcohol con-
sumption, the hangover-immune and hangover group did not
differ on the total number of alcoholic drinks consumed
(10.7 ± 4.7 versus 12.5 ± 7.3 drinks) and the estimated BAC
that was achieved (0.17 ± 0.07 versus 0.19 ± 0.09 %). As
expected, overall hangover severity was significantly higher
in the hangover group when compared to the hangover-
immune group (5.6 ± 2.4 versus 0.7 ± 1.4, p = 0.006).
Table 1 gives an overview of the urine ethanol concentra-
tions, as determined on the hangover and control day.
On the hangover day, residual ethanol was present in 31 of
36 corresponding urine samples (86.1 %). Overall (N = 36),
the urine ethanol concentration (p = 0.002) was significantly
higher on the hangover day when compared to control day.
For the hangover group, on the hangover day, a significantly
higher urine ethanol concentration (p = 0.006) was found
when compared to the control day. For the hangover-
immune group, no significant differences were observed for
Table 1 Urine ethanol
determinations Hangover group urine ethanol (mg/L) Hangover-immune group urine ethanol (mg/L)
Subject Control day Hangover day Subject Control day Hangover day
S101 11.91 48.36 S201 1.23 6.28
S102 0.52 3.58 S202 1.94 6.20
S103 0 476.03 S203 1.35 0.60
S104 1.27 338.26 S204 2.03 2.65
S105 0.45 366.12 S205 0 2.44
S106 0.18 2.34 S206 1.25 42.32
S107 1.66 1.24 S207 3.93 1.47
S108 2.18 438.79 S208 0 436.69
S109 7.98 0.87 S209 1.96 3.22
S110 1.94 800.18 S210 2.17 1.99
S111 1.93 2.63 S211 0.58 2.51
S112 0.25 307.92 S212 0.85 26.44
S113 0.32 1.01 S213 0.24 0
S114 0.21 0.93 S214 0.25 9.34
S115 11.27 1.59 S215 0.4 0.60
S116 5.04 431.92 S216 0.46 3.35
S117 1.93 77.21 S217 0.5 1.07
S118 0.37 35.84 S218 1.08 61.66
Mean 2.75 185.27* Mean 1.12 33.82
SD 3.78 240.23 SD 1 101.93
Range 0–11.91 0.87–800.18 Range 0–3.93 0–436.69
Mean, standard deviation (SD), and range are presented. Significant differences (p < 0.05) between the hangover
group and hangover-immune group are indicated by an asterisk
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urine ethanol levels between the hangover and control day.
Urine ethanol concentration on the hangover day was signif-
icantly higher in the hangover group when compared to the
hangover-immune group (p = 0.027). No differences between
the two groups were observed on the control day.
The 1-item hangover severity score did not significantly
correlate with urine ethanol concentration. Regarding individ-
ual hangover symptoms, overall (N = 36), a significant corre-
lation was found with nausea (r = 0.386, p = 0.020), headache
(r = 0.392, p = 0.018), and sleep problems (r = 0.364,
p = 0.029). When analyzing the data for the two groups sep-
arately, a clear distinction became evident (see Table 2).
In the hangover-immune group, none of the correlations of
ethanol concentration with individual hangover symptoms
was significant. In contrast, in the hangover group, significant
correlations were found between urine ethanol concentration
and nausea (r = 0.602, p = 0.008), headache (r = 0.513,
p = 0.030), concentration problems (r = 0.633, p = 0.005),
regret (r = 0.512, p = 0.030), sleepiness (r = 0.646,
p = 0.004), shaking (r = 0.517, p = 0.028), weakness
(r = 0.492, p = 0.038), dizziness (r = 0.534, p = 0.022), sweat-
ing (r = 0.640, p = 0.004), confusion (r = 0.520, p = 0.027),
thirst (r = 0.599, p = 0.009), heart racing (r = 0.550,
p = 0.018), and sleep problems (r = 0.552, p = 0.017).
Discussion
Next day urine ethanol concentration was significantly
higher on hangover day compared to control day. Also,
urine ethanol concentration was significantly higher in
the hangover group when compared to the hangover-
immune group. In the hangover-immune group, none of
the correlations of urine ethanol concentration with indi-
vidual hangover symptoms was significant. In contrast,
in the hangover group, significant correlations were
found with a variety of hangover symptoms, including
nausea, headache, concentration problems, regret, sleepi-
ness, shaking, weakness, dizziness, sweating, confusion,
thirst, heart racing, and sleep problems.
Thus, among participants who experienced a hangover, a
clear significant relationship was observed between urine eth-
anol concentration and a variety of hangover symptoms. This
association was not seen in participants claiming to be hang-
over free. No differences in demographics or alcohol con-
sumption were observed between the hangover group and
the hangover-immune group that can explain our findings.
For example, total alcohol consumed and estimated peak
BAC did not significantly differ between the hangover group
and the hangover-immune group.
It can be hypothesized that the difference between the
hangover group and hangover-immune group regarding
urine ethanol concentrations and experiencing hangover
symptoms is related to variations in alcohol metabolism.
Administration of ethanol causes the production of acet-
aldehyde as an intermediate metabolite. Aldehyde dehy-
drogenase (ALDH) further metabolizes acetaldehyde to
acetate. Perhaps, fast metabolizers of ethanol and acetal-
dehyde do not reach peak BAC levels that would be ex-
pected when using common formulas such as those by
Matthews and Miller (1979). Rapid elimination of alcohol
could be an explanation why fast metabolizers may claim
to be hangover immune, despite consuming the same
amount of alcohol as slow metabolizers. Further studies
are needed to examine the role of ethanol metabolism in
the pathology of alcohol hangover. In such studies, alco-
hol should be administered to achieve a target BAC in
participants with a hangover versus hangover-immune
subjects. Then, the realized peak BAC and the rate of
ethanol elimination can be directly compared. If such a
study confirms a lower peak BAC and faster ethanol elim-
ination in hangover-immune drinkers, this would support












Concentration problems 0.633** 0.102
Nausea 0.602** 0.310
Thirst 0.599** 0.149
Sleep problems 0.552* 0.255








Stomach pain 0.422 0.146
Heart beating 0.422 −0.183
Anxiety 0.411 −0.341
Depression 0.400 0.034
Reduced appetite 0.379 −0.180




Significant correlations are indicated by *(p < 0.05) or **(p < 0.01)
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the idea that fast metabolizers may be hangover immune
because they do not reach high enough BAC levels to
provoke a hangover (Verster et al. 2013).
Alternatively, not ethanol itself but its metabolites
may be related to experiencing hangover symptoms and
have an impact on their severity. For example, several
studies have suggested that acetaldehyde concentration
may also be an important factor determining the presence
and severity of alcohol hangover (Eriksson 1983;
Tsukamoto et al. 1991; Ylikahri et al. 1974). During
analyses of our urine samples for ethanol content, two
unidentified peaks appeared in each chromatogram at a
retention time of 2.348 and 6.593. Based on literature, a
trial run was performed on the congeners 2-butanol, iso-
butanol, 2-methyl-1-butanol, 3-methyl-1-butanol, and 1-
propanol, and metabolites of ethanol acetaldehyde, and
acetone. The trial runs were repeated three times, using
different gradients. The first peak was identified to be
acetaldehyde (RT = 2.348), the second as acetone
(RT = 6.593). Future analyses should investigate the po-
tential role of acetaldehyde in the pathology of alcohol
hangover.
Although the observed associations have considerable
strength, some limitations of the current study should be ad-
dressed. Limitations that are common to a naturalistic study
design also apply to the current investigation. For example,
alcohol consumption, sleep time, and participant behavior in
general were not controlled by the investigators. Although all
urine samples were collected around 9.30 am, the time be-
tween stopping alcohol consumption and sample collection
varied between participants. Further, although (alcoholic and
non-alcoholic) beverage consumption was recorded, it is not
known to what extent participants consumed water during the
night, nor was it recorded whether or not they urinated during
the night or early morning. Voiding urine during this period of
time may have caused excretion of ethanol. It is unclear to
what extent these variations may have had an impact on the
study outcome. On the other hand, at a group level, variables
related to alcohol consumption, sleep, and demographics do
not differ significantly between the hangover group and the
hangover-immune group, suggesting that their impact on the
study outcome is limited.
Taken together, in the hangover group ethanol levels
showed to be significantly associated with the presence and
severity of several hangover symptoms. In contrast, in the
hangover-immune group ethanol concentration on the hang-
over day did not differ significantly from the control day, and
these individuals did not report experiencing typical hangover
symptoms. This observation suggests that hangover-immune
individuals may be fast metabolizers of alcohol, that do not
reach the peak BAC required to provoke an alcohol hangover.
More research into the association between hangover severity
and ethanol metabolism is therefore warranted.
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